DIFFERENTIAL-EFFECTS OF DOPAMINE-D2 AGONIST QUINPIROLE UPON THE DORSAL IMMOBILITY RESPONSE IN RATS

被引:6
作者
MEYER, ME
MEYER, ME
POTTER, TJ
VANHARTESVELDT, C
机构
[1] Department of Psychology, University of Florida, Gainesville
关键词
QUINPIROLE; DOPAMINE; D2-RECEPTOR; BIPHASIC EFFECT; DORSAL IMMOBILITY RESPONSE;
D O I
10.1016/0091-3057(92)90524-J
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The effects of various dose levels of systemically injected quinpirole upon the dorsal immobility response (DIR) over a time course was investigated in male rats. A low dose of quinpirole (0.01 mg/kg) significantly attenuated the duration of the DIR following the 10-min interval, whereas the highest dose (1.0 mg/kg) had a biphasic effect so that at the 10-min interval the duration of the DIR was significantly potentiated and at the 60-min interval the duration of the DIR was significantly attenuated. The intermediate dose (0.1 mg/kg) had intermediate behavioral effects. The data support the growing evidence that quinpirole has differential effects upon behavior over time as a function of the dose levels. The present data were discussed in reference to presynaptic and postsynaptic dopamine D2 receptor theory.
引用
收藏
页码:257 / 259
页数:3
相关论文
共 50 条
  • [21] Dopamine D2/D3 receptor agonist quinpirole impairs spatial reversal learning in rats: investigation of D3 receptor involvement in persistent behavior
    Vasileios Boulougouris
    Anna Castañé
    Trevor W. Robbins
    Psychopharmacology, 2009, 202 : 611 - 620
  • [22] The effects of the dopamine D2 agonist sumanirole on prepulse inhibition in rats
    Weber, Martin
    Chang, Wei-Li
    Breier, Michelle R.
    Yang, Alex
    Millan, Mark J.
    Swerdlow, Neal R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 (06) : 421 - 425
  • [23] Dopamine D2/D3 receptor agonist quinpirole impairs spatial reversal learning in rats: investigation of D3 receptor involvement in persistent behavior
    Boulougouris, Vasileios
    Castane, Anna
    Robbins, Trevor W.
    PSYCHOPHARMACOLOGY, 2009, 202 (04) : 611 - 620
  • [24] Perinatal Treatments with the Dopamine D2-Receptor Agonist Quinpirole Produces Permanent D2-Receptor Supersensitization: a Model of Schizophrenia
    Kostrzewa, Richard M.
    Nowak, Przemyslaw
    Brus, Ryszard
    Brown, Russell W.
    NEUROCHEMICAL RESEARCH, 2016, 41 (1-2) : 183 - 192
  • [25] ANTICONVULSANT EFFECTS OF IPSILATERAL BUT NOT CONTRALATERAL MICROINJECTIONS OF THE DOPAMINE-D2 AGONIST LY-171555 INTO THE NUCLEUS-ACCUMBENS OF AMYGDALA-KINDLED RATS
    WAHNSCHAFFE, U
    LOSCHER, W
    BRAIN RESEARCH, 1991, 553 (02) : 181 - 187
  • [26] Perinatal Treatments with the Dopamine D2-Receptor Agonist Quinpirole Produces Permanent D2-Receptor Supersensitization: a Model of Schizophrenia
    Richard M. Kostrzewa
    Przemysław Nowak
    Ryszard Brus
    Russell W. Brown
    Neurochemical Research, 2016, 41 : 183 - 192
  • [27] SELECTIVE D(1)-DOPAMINE AND D(2)-DOPAMINE RECEPTOR ANTAGONISTS PRODUCED DIFFERENTIAL-EFFECTS ON REACTION-TIME IN THE RAT
    MAYFIELD, RD
    RANDALL, PK
    SPIRDUSO, WW
    WILCOX, RE
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1993, 46 (04) : 759 - 768
  • [28] Hyperactivity induced by the dopamine D2/D3 receptor agonist quinpirole is attenuated by inhibitors of endocannabinoid degradation in mice
    Jesus Luque-Rojas, Maria
    Galeano, Pablo
    Suarez, Juan
    Araos, Pedro
    Santin, Luis J.
    Rodriguez de Fonseca, Fernando
    Blanco Calvo, Eduardo
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2013, 16 (03) : 661 - 676
  • [29] Carbamazepine prevents imipramine-induced behavioural sensitization to the dopamine D2-like receptor agonist quinpirole
    D'Aquila, PS
    Peana, AT
    Tanda, O
    Serra, G
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 416 (1-2) : 107 - 111
  • [30] Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats
    Melissa L. Perreault
    Dawn Graham
    Sarah Scattolon
    Yufang Wang
    Henry Szechtman
    Jane A. Foster
    Psychopharmacology, 2007, 194 : 485 - 496